Michael Robert A. — SEC Form 4 filings
SEC reporting owner CIK 1699914. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-02-20 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 68,879 shares, $12,153,957 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 47,319 shares @ $176.46 ($8,349,911) in AbbVie Inc., filed 2024-03-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | CHAIRMAN OF THE BOARD AND CEO, Director | 6 | — | 2 legs · 68,879 sh · $12,153,957 | 22 |
Form 4 filings — Michael Robert A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-03 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 36,523 @ $232.08 | EDGAR |
| 2026-02-20 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 33,833 @ $0 · Grant/award (A): 12,030 @ $0 · Grant/award (A): 14,452 @ $0 · Grant/award (A): 22,124 @ $0 · Grant/award (A): 81,251 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 27,186 @ $205.02 | EDGAR |
| 2025-02-18 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 24,732 @ $0 · Grant/award (A): 10,146 @ $0 · Grant/award (A): 12,030 @ $0 · Grant/award (A): 14,454 @ $0 · Grant/award (A): 83,333 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 37,638 @ $178.99 · Option exercise (M): 11,420 @ $61.36 · Option exercise (M): 10,140 @ $54.86 · Sale (S): 21,560 @ $176.44 · Sale (S): 47,319 @ $176.46 · Option exercise (M): 11,420 (derivative) @ $61.36 · +1 more | EDGAR |
| 2024-02-20 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 49,565 @ $0 · Grant/award (A): 13,216 @ $0 · Grant/award (A): 10,146 @ $0 · Grant/award (A): 12,030 @ $0 · Grant/award (A): 59,888 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1699914 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →